Company Filing History:
Years Active: 2011-2012
Title: The Innovative Contributions of Ka Sing Yeung in Breast Cancer Detection
Introduction
Ka Sing Yeung, an inventive mind based in Wiarton, Canada, has made significant strides in the field of medical technology, particularly with innovations aimed at breast cancer detection. With a total of two patents to his name, Yeung's work focuses on simplifying the screening process for detecting neoplasia and breast cancer, potentially revolutionizing the way these conditions are diagnosed and managed.
Latest Patents
Ka Sing Yeung's latest patents include groundbreaking inventions that pertain to methods and systems for breast cancer detection and risk assessment. These inventions relate to a straightforward screening test designed for identifying neoplasia, a precancerous condition, or established breast cancer. His patented method involves detecting a specific breast cancer marker in breast fluid by treating samples with an aldehyde detecting reagent, such as Schiff's reagent, without any prewashing. Remarkably, the presence of this marker in breast fluids has been shown to correlate significantly with the disease status of the breast cancer subjects from which the samples were derived. Moreover, Yeung's patents also encompass the development of screening test kits to aid in this vital early detection process.
Career Highlights
Throughout his career, Ka Sing Yeung has had the opportunity to work with esteemed organizations such as the Dr. Susan Love Research Foundation and Atossa Genetics, Inc. His contributions to these institutions have been instrumental in advancing research and practical applications in breast health.
Collaborations
In his professional journey, Yeung has collaborated with esteemed colleagues including Jiri Jan Krepinsky and Rudolf Furrer. These partnerships have fostered knowledge exchange and further enhanced the innovative processes within the medical technology sector.
Conclusion
Ka Sing Yeung stands as a prominent figure in the field of medical innovation, particularly in breast cancer detection. His patents reflect a commitment to enhancing patient outcomes through improved screening methods. As research in this area continues to evolve, Yeung's contributions may pave the way for more effective and accessible breast cancer diagnostic tools.